These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1971114)

  • 1. Enhancement of freezing behaviour by metoclopramide: implications for neuroleptic-induced avoidance deficits.
    Blackburn JR; Phillips AG
    Pharmacol Biochem Behav; 1990 Mar; 35(3):685-91. PubMed ID: 1971114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of acquisition of one-way conditioned avoidance responding by haloperidol and metoclopramide but not by thioridazine or clozapine: implications for screening new antipsychotic drugs.
    Blackburn JR; Phillips AG
    Psychopharmacology (Berl); 1989; 98(4):453-9. PubMed ID: 2570431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response decrement patterns after neuroleptic and non-neuroleptic drugs.
    Sanger DJ
    Psychopharmacology (Berl); 1986; 89(1):98-104. PubMed ID: 2874584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of conditioned suppression to evaluate the nature of neuroleptic-induced avoidance deficits.
    Beninger RJ; Mason ST; Phillips AG; Fibiger HC
    J Pharmacol Exp Ther; 1980 Jun; 213(3):623-7. PubMed ID: 6110768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of bromopride and domperidone effects on rat conditioned avoidance and motor activity.
    Nasello AG; Vanzeler ML; Felicio LF
    Pharmacol Toxicol; 1991 Jan; 68(1):46-50. PubMed ID: 2008411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of clozapine, metoclopramide, haloperidol and risperidone on acquisition and performance of operant responding in rats.
    Baker TW; Florczynski MM; Beninger RJ
    Psychopharmacology (Berl); 2015 May; 232(9):1535-43. PubMed ID: 25381749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scopolamine does not restore normal conditioned avoidance performance in raclopride-treated rats.
    Ahlenius S; Ericson E
    J Neural Transm (Vienna); 2001; 108(4):415-30. PubMed ID: 11475009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The actions of SCH 23390, a D1 receptor antagonist, on operant and avoidance behavior in rats.
    Sanger DJ
    Pharmacol Biochem Behav; 1987 Mar; 26(3):509-13. PubMed ID: 3554270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats.
    Shannon HE; Hart JC; Bymaster FP; Calligaro DO; DeLapp NW; Mitch CH; Ward JS; Fink-Jensen A; Sauerberg P; Jeppesen L; Sheardown MJ; Swedberg MD
    J Pharmacol Exp Ther; 1999 Aug; 290(2):901-7. PubMed ID: 10411607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute bromopride treatments: effects on general activity and inhibitory avoidance in rats.
    Nasello AG; Felicio LF
    Braz J Med Biol Res; 1988; 21(4):841-3. PubMed ID: 3240380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of lithium chloride-induced conditioned place aversion as a test for antiemetic agents: comparison of metoclopramide with combined extracts of Zingiber officinale and Ginkgo biloba.
    Frisch C; Hasenöhrl RU; Mattern CM; Häcker R; Huston JP
    Pharmacol Biochem Behav; 1995 Oct; 52(2):321-7. PubMed ID: 8577797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avoidance-suppressing effect of antipsychotic drugs is progressively potentiated after repeated administration: an interoceptive drug state mechanism.
    Mead A; Li M
    J Psychopharmacol; 2010 Jul; 24(7):1045-53. PubMed ID: 19329544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new computer-assisted two-way avoidance conditioning equipment for rats: behavioral and pharmacological validation.
    Salmi P; Samuelsson J; Ahlenius S
    J Pharmacol Toxicol Methods; 1994 Nov; 32(3):155-9. PubMed ID: 7858309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine and haloperidol reinstate latent inhibition following its disruption during amphetamine withdrawal.
    Russig H; Murphy CA; Feldon J
    Neuropsychopharmacology; 2002 Jun; 26(6):765-77. PubMed ID: 12007747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiamnesic activity of metoclopramide, cisapride and SR-17 in the mouse passive avoidance test.
    Galeotti N; Ghelardini C; Teodori E; Gualtieri F; Bartolini A
    Pharmacol Res; 1997 Jul; 36(1):59-67. PubMed ID: 9368916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subchronic administration of clozapine, but not haloperidol or metoclopramide, decreases dopamine D2 receptor messenger RNA levels in the nucleus accumbens and caudate-putamen in rats.
    See RE; Lynch AM; Sorg BA
    Neuroscience; 1996 May; 72(1):99-104. PubMed ID: 8730709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a stable CCK agonist (A68552) in conditioned avoidance responding in mice, rats, and primates: comparison with typical and atypical antipsychotics.
    Britton DR; Curzon P; Yahiro L; Buckley M; Tufano M; Nadzan A
    Pharmacol Biochem Behav; 1992 Oct; 43(2):369-76. PubMed ID: 1359571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of extinction to investigate the nature of neuroleptic-induced avoidance deficits.
    Beninger RJ; Mason ST; Phillips AG; Fibiger HC
    Psychopharmacology (Berl); 1980; 69(1):11-8. PubMed ID: 6104843
    [No Abstract]   [Full Text] [Related]  

  • 19. Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations.
    Costall B; Naylor RJ
    Br J Pharmacol; 1995 Dec; 116(7):2989-99. PubMed ID: 8680734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buspirone, gepirone and ipsapirone disrupt both active and passive avoidance responding in rats.
    Sanger DJ; Joly D; LePichon M
    Behav Pharmacol; 1989; 1(2):153-160. PubMed ID: 11175398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.